Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update

Julia Lee
February 14, 2018

Equity Investor 12 February

Julia Lee
February 13, 2018

Weekly Wrap 9 February

Julia Lee
February 9, 2018

Equity Investor 5 February

Julia Lee
February 6, 2018

Market Update

Julia Lee
February 6, 2018

Market Update

Julia Lee
February 5, 2018

Weekly Wrap 2 February

Julia Lee
February 5, 2018

Market Update

Julia Lee
February 2, 2018

Market Update

Julia Lee
February 1, 2018

Market Update

Julia Lee
January 31, 2018

Market Update

Julia Lee
January 30, 2018

Equity Investor 29 Jan

Julia Lee
January 30, 2018